Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypolipidemic therapy and cholesterol absorption.

Amit Manhas1, John A Farmer

  • 1Section of Cardiology, Baylor College of Medicine, One Baylor Plaza, MS 523D, Houston, TX 77030, USA.

Current Atherosclerosis Reports
|March 17, 2004
PubMed
Summary

New therapies like ezetimibe offer effective cholesterol absorption inhibition. This approach, alongside statins, helps achieve lipid goals when other treatments fail or cause side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generation of an induced pluripotent stem cell line from a patient with Loeys-Dietz syndrome.

Stem cell research·2026
Same author

Profiling Immune-Independent Response to Immune Checkpoint Inhibitors on Stem Cell-Derived Cardiomyocytes, Organoids, and Mouse Models.

Circulation·2026
Same author

Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotective.

Science translational medicine·2025
Same author

Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA vaccination.

Science translational medicine·2025
Same author

Generation of an induced pluripotent stem cell line from a patient with Varicose veins.

Stem cell research·2025
Same author

Generation of an induced pluripotent stem cell line from a malignant melanoma patient who developed the immune checkpoint inhibitor-related myasthenia gravis, myositis, and myocarditis overlap syndrome.

Stem cell research·2025

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Gastroenterology

Background:

  • Hypolipidemic therapy, particularly statins, has improved lipid profile management.
  • Lipid goals are often unmet due to insufficient response or adverse effects.
  • Combination therapy can enhance low-density lipoprotein cholesterol reduction.

Purpose of the Study:

  • To review pharmacologic agents that reduce cholesterol absorption.
  • To highlight the role of ezetimibe and colesevelam in lipid management.
  • To discuss combination therapy strategies for optimizing lipid profiles.

Main Methods:

  • Review of existing literature on hypolipidemic agents.
  • Focus on agents acting via cholesterol absorption inhibition.
  • Comparison of ezetimibe and colesevelam with other lipid-lowering drugs.

Main Results:

  • Ezetimibe effectively inhibits gastrointestinal cholesterol absorption with minimal systemic absorption.
  • Ezetimibe offers a favorable safety profile, lacking significant drug interactions common with bile acid resins.
  • Combination therapy with ezetimibe provides an alternative for patients not achieving goals with monotherapy.

Conclusions:

  • Ezetimibe represents a new class of cholesterol absorption inhibitors.
  • Ezetimibe is a viable option for monotherapy or combination therapy to optimize lipid profiles.
  • Agents like ezetimibe and colesevelam are crucial for managing dyslipidemia when other treatments are inadequate.

Related Experiment Videos